PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2

Marta Terrile, Irene Appolloni, Filippo Calzolari, Roberto Perris, Evelina Tutucci, Paolo Malatesta*

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review


Background: In the last years, the transmembrane proteoglycan NG2 has gained interest as a therapeutic target for the treatment of diverse tumor types, including gliomas, because increases of its expression correlate with dismal prognosis. NG2 has been shown to function as a co-receptor for PDGF ligands whose aberrant expression is common in gliomas. We have recently generated a glioma model based on the overexpression of PDGF-B in neural progenitors and here we investigated the possible relevance of NG2 during PDGF-driven gliomagenesis.Methods: The survival curves of NG2-KO mice overexpressing PDGF-B were compared to controls by using a Log-rank test. The characteristics of tumors induced in NG2-KO were compared to those of tumors induced in wild type mice by immunostaining for different cell lineage markers and by transplantation assays in adult mice.Results: We showed that the lack of NG2 does not appreciably affect any of the characterized steps of PDGF-driven brain tumorigenesis, such as oligodendrocyte progenitor cells (OPC) induction, the recruitment of bystander OPCs and the progression to full malignancy, which take place as in wild type animals.Conclusions: Our analysis, using both NG2-KO mice and a miRNA based silencing approach, clearly demonstrates that NG2 is not required for PDGF-B to efficiently induce and maintain gliomas from neural progenitors. On the basis of the data obtained, we therefore suggest that the role of NG2 as a target molecule for glioma treatment should be carefully reconsidered.

Original languageEnglish
Article number550
JournalBMC Cancer
Publication statusPublished - 12 Oct 2010
Externally publishedYes


Dive into the research topics of 'PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2'. Together they form a unique fingerprint.

Cite this